Parkinson Disease Clinical Trials in Rochester, New York

3 studies are recruiting for parkinson disease in Rochester, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic p…

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    University of Rochester, Rochester, New York
    Locations
    72 in total
    Run by
    Neuron23 Inc.

    See if you can join NCT06680830 on ClinicalTrials.gov

  2. Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

    The goal of this clinical trial is two-fold. First to investigate the feasibility of whether a remotely administered smartphone app can increase the volume and intensity of physical activity in daily life in individuals with a LRRK2 G2019S or GBA1 N370S genetic mutation over a long period of time (…

    Stage
    Not phased
    Ages
    50 and older
    Site
    University of Rochester Center for Health and Technology (CHeT), Rochester, New York
    Locations
    2 in total
    Run by
    Radboud University Medical Center

    See if you can join NCT06993142 on ClinicalTrials.gov

  3. PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

    The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest…

    Stage
    Not phased
    Ages
    30 and older
    Site
    University of Rochester, Rochester, New York
    Locations
    50 in total
    Run by
    Michael J. Fox Foundation for Parkinson's Research

    See if you can join NCT04477785 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.